Oberweis Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Oberweis Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-42,300	Closed	-$495K	–	158
2020 Q3	$495K	Hold	42,300	–	–	0.17%	83
2020 Q2	$550K	Sell	42,300 -5,000	-11%	-$60.1K	0.22%	82
2020 Q1	$438K	Sell	47,300 -17,900	-27%	-$250K	0.24%	103
2019 Q4	$1.08M	Buy	65,200 +6,300	+11%	+$102K	0.36%	62
2019 Q3	$980K	Buy	+58,900	New	+$815K	0.22%	69

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oberweis Asset Management's OXFD Position: Q4 2020 in Review

Oberweis Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 42,300 shares — an estimated $495K sold.

Oberweis Asset Management first reported a position in OXFD in Q3 2019 and held it in 5 quarters. The position peaked at $1.08M in Q4 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

Oberweis Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Oberweis Asset Management sold 42,300 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $495K.
Oberweis Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 5 quarters.
Oberweis Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.08M in Q4 2019.
60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Oberweis Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.